The upregulation of miR-221/222 can promote the growth of hepatocellular carcinoma (HCC) cells by increasing the number of S-phase cells, and the oncogenic activity of miR-221 is believed to be realized through the regulation of CDKN1B (42, 43). Here, CDKN1B is linked to hepatocellular carcinoma.